Victoria Haldane

Victoria Haldane

Auto-generated profile, based on publicly available information

Victoria Haldane

Dalla Lana School of Public Health, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
VHVictoria Haldane
Victoria Haldane
CFChuan De Foo
Chuan De Foo
SASalma M. Abdalla
Salma M. Abdalla
AJAnne-Sophie Jung
Anne-Sophie Jung
MTMelisa Tan
Melisa Tan
HLHelena Legido-Quigley
Helena Legido-Quigley

14 December 2020 in Health Policy and Planning
Verified
Journal Article
Open access
PDF file
VHVictoria Haldane
Victoria Haldane
GMGarrett T Morgan
Garrett T Morgan
As countries confront and adapt to the impact of COVID-19, policymakers, public health officials and political leaders have rallied around one word: resilience. Resilience often narrowly focuses on ‘bouncing back’ to normal as quickly as possible, without critically assessing whether the pre-shock normal should be aspired to ( Ebi and Semenza, 2008; Houston, 2015). We argue that the COVID-19 pandemic presents an opportunity for health systems to address the long-standing structural inequalities it reinforces, and the environmental sustainability it undermines, to work towards transformative resilience, or ‘transilience’ ( Pelling, 2010) .

28 May 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
VHVictoria Haldane
Victoria Haldane
JKJoel Jun Kai Koh
Joel Jun Kai Koh
ASAastha Srivastava
Aastha Srivastava
KTKrichelle Wei Qi Teo
Krichelle Wei Qi Teo
YTYao Guo Tan
Yao Guo Tan
HLHelena Legido-Quigley
Helena Legido-Quigley
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The use of mHealth has gained popularity globally including for use in variety of health interventions, particularly through SMS. However, there are challenges to the use of mHealth, particularly amongst older users who have a large heterogeneity in usability and accessibility barriers when using technology. In order to better understand and conceptualise the diversity of users and give insight into their particular needs, we turned to persona creation. Personas are user archetypes created through data generated from mixed-methods inquiry with actual target users. Personas are an appropriate yet largely underutilised component of current mHealth research. Methods: Leveraging on data from a mixed methods study conducted in Singapore with an ethnically diverse population including Chinese, Malay and Indian participants, we used a proforma to analyse data from the qualitative component (n=20 in-depth interviews) and quantitative component (n=100 interviewer guided surveys). We then identified key characteristics including technology use and preferences as well as adherence factors to synthesize five personas reflective of persons over the age of 40 years old with atherosclerotic cardiovascular disease (ASCVD) or ASCVD risk factors such as hypertension, in Singapore. Results: We present five personas typologized as 1) The Quiet Analog, 2) The Busy Grandparent, 3) The Socializer, 4) The Newly Diagnosed and 5) The Hard-to-Reach. We report on four key characteristics - health care access, medication adherence, mobile phone technology usage (ownership, access and utilization) and interest in mHealth. Finally, we provide insights into how these personas may be used in the design and implementation of an mHealth intervention. Our work demonstrates how mixed methods data can create biopsychosocial personas which can be used to explore and address the diversity in behaviours, preferences and needs in user groups. Conclusion: With wider adoption of mHealth, it is important that we consider user-centered design techniques, and design thinking in order to create meaningful, patient centered interventions for adherence to medications. Future research in this area should include greater exploration of how these five personas can be used to better understand how and when is best to deliver mHealth interventions in Singapore and beyond.

12 May 2022 in Implementation Science
Verified
Journal Article
Open access
PDF file
SWShishi Wu
Shishi Wu
ETelias edward tannous
elias edward tannous
VHVictoria Haldane
Victoria Haldane
MEMoriah E. Ellen
Moriah E. Ellen
Xiaolin WeiXiaolin Wei
Xiaolin Wei
Background: Behavior change interventions that aim to improve rational antibiotic use in prescribers and users have been widely conducted in both high- and LMICs. However, currently, no review has systematically examined challenges unique to LMICs and offered insights into the underlying contextual factors that influence these interventions. We adopted an implementation research perspective to systematically synthesize the implementation barriers and facilitators in LMICs. Methods: We conducted literature searches in five electronic databases and identified studies that involved the implementation of behavior change interventions to improve appropriate antibiotic use in prescribers and users in LMICs and reported implementation barriers and facilitators. Behavior change interventions were defined using the behavior change wheel, and the coding and synthesis of barriers and facilitators were guided by the Consolidated Framework for Implementation Research (CFIR). Results: We identified 52 eligible studies, with the majority targeting prescribers practicing at tertiary facilities (N=39, 75%). The most commonly reported factors influencing implementation were found in the inner setting domain of the CFIR framework, particularly related to constraints in resources and the infrastructure of the facilities where interventions were implemented. Barriers related to the external policy environment (e.g., lack of national initiatives and policies on antibiotic use), and individual characteristics of target populations (e.g., reluctance to change prescribing behaviors) were also common, as well as facilitators related to intervention characteristics (e.g., embedding interventions in routine practice) and process (e.g., stakeholder engagement). We also provided insights into the interrelationships between these factors and the underlying causes contributing to the implementation challenges in LMICs. Conclusion: We presented a comprehensive overview of the barriers and facilitators of implementing behavior change interventions to promote rational antibiotic use in LMICs. Our findings suggest that facilitating the implementation of interventions to improve rational antibiotic use needs comprehensive efforts to address challenges at policy, organizational, and implementation levels. Specific strategies include (1) strengthening political commitment to prompt mobilization of domestic resources and formulation of a sustainable national strategy on AMR, (2) improving the infrastructure of health facilities that allow prescribers to make evidence-based clinical decisions, and (3) engaging local stakeholders to improve their buy-in and facilitate contextualizing interventions. Trial registration: PROSPERO: CRD42021252715.

28 November 2021 in BMJ
Verified
Journal Article
Open access
PDF file
VHVictoria Haldane
Victoria Haldane
AJAnne-Sophie Jung
Anne-Sophie Jung
CFChuan De Foo
Chuan De Foo
MBMathias Bonk
Mathias Bonk
MJMargaret Jamieson
Margaret Jamieson
HLHelena Legido-Quigley
Helena Legido-Quigley
Victoria Haldane and colleagues argue that to make covid-19 the last pandemic, public health responses to outbreaks must be strengthened, starting with their most basic functions

13 February 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VHVictoria Haldane
Victoria Haldane
AAArchchun Ariyarajah
Archchun Ariyarajah
IBIsha Berry
Isha Berry
MLMiranda Loutet
Miranda Loutet
FSFabio Salamanca-Buentello
Fabio Salamanca-Buentello
RURoss E G Upshur
Ross E G Upshur
Introduction: The COVID-19 pandemic has amplified pre-existing challenges to health promotion and care across the world, and particularly in low- and middle-income countries (LMICs). This qualitative study draws on data from a panel of immunisation experts and uses a novel framework of vaccine delivery domains to explore perspectives from those who live and work in these settings on the challenges to implementing COVID-19 vaccine programs in LMICs. Methods: We conducted a thematic content analysis of 96 participant free text replies to questions from Round I of a three-round Delphi consensus study amongst global experts on COVID-19 vaccine implementation. Results: Participant responses highlighted challenges to vaccine program implementation including issues related to equity; governance, decision-making, and financing; regulatory structures, planning, and coordination; prioritisation, demand generation, and communication; vaccine, cold chain, logistics, and infrastructure; service delivery, human resources, and supplies; and surveillance, monitoring, and evaluation. Conclusion: We reflect on our findings in light of global efforts to address vaccine inequity and emphasise three key areas salient to improving vaccination efforts during novel infectious disease outbreaks: 1) Ensuring safe and sustainable service delivery in communities and at points of care; 2) Strengthening systems for end-to-end delivery of vaccines, therapeutics, diagnostics, and essential supplies; 3) Transforming structural paradigms towards vaccine equity.